date,title,source
Oct-18-18,"""...Amidst Market Volatility"" Vista Partners' October Macroeconomic & Investment Monthly Newsletter",ACCESSWIRE
Oct-25-18,"Report: Exploring Fundamental Drivers Behind Atossa Genetics, Titan International, Olympic Steel, L Brands, Sysco, and TiVo  New Horizons, Emerging Trends, and Upcoming Developments",GlobeNewswire
Nov-13-18,Atossa Genetics Announces Third Quarter 2018 Financial Results And Provides Company Update,GlobeNewswire
Nov-21-18,''A Spate of Factors'' Vista Partners November 2018 Macro Economic and Investment Newsletter,ACCESSWIRE
Dec-07-18,Edison issues outlook on Atossa Genetics (ATOS),GlobeNewswire
Dec-19-18,"""The Roller Coaster Ride Continues""",ACCESSWIRE
Dec-28-18,"Detailed Research: Economic Perspectives on American Airlines Group, Sandstorm Gold, Kala Pharmaceuticals, Adecoagro S.A, Novagold Resources, and Atossa Genetics  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Jan-09-19,4 Healthcare Stocks Looking To Set January Highs,ACCESSWIRE
Jan-09-19,Atossa Genetics Announces Successful Completion and Final Results from Male Phase 1 Study of Topical Endoxifen,GlobeNewswire
Jan-10-19,Today's Research Reports on Trending Tickers: BioTelemetry and Atossa Genetics,ACCESSWIRE
Jan-30-19,Vista Partners January 2019 Monthly Macroeconomic and Investment Newsletter,ACCESSWIRE
Feb-04-19,Atossa Genetics Provides Breast Cancer Prevention Recommendations to the United States Preventative Services Task Force,GlobeNewswire
Feb-07-19,Atossa Genetics Reports Results From Expanded Access Program for a U.S. Breast Cancer Patient Taking Oral Endoxifen: Sizeable Reduction in Cancer Cell Biological Activity; No Safety or Tolerability Issues,GlobeNewswire
Feb-27-19,"""On Fed's Wings"" Vista Partners Publishes February 2019's Macroeconomic & Investment Monthly Newsletter",ACCESSWIRE
Mar-14-19,What Type Of Shareholder Owns Atossa Genetics Inc.s (NASDAQ:ATOS)?,Simply Wall St.
Mar-14-19,Atossa Genetics News: FDA Approval Sends ATOS Stock Skyrocketing,InvestorPlace
Mar-14-19,Atossa Genetics Announces FDA Approval of Oral Endoxifen for Expanded Access as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient,GlobeNewswire
Mar-18-19,Atossa Genetics Announces Receipt of $10 Million,GlobeNewswire
Mar-26-19,Atossa Genetics Announces Institutional Review Board Approval of Oral Endoxifen as Post-Mastectomy Treatment for a U.S. Breast Cancer Patient,GlobeNewswire
Mar-27-19,"""Bull Market Hopping?""",ACCESSWIRE
Mar-28-19,Atossa Genetics Announces Year End 2018 Financial Results and Provides Company Update,GlobeNewswire
